EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Secreted PEBP4 promotes colorectal cancer progression via regulation of the TGF-β signaling pathway

Zhimin Tang, Ting Li, Zaiqi Yang, Yilan Zhang, Yan Zhou, Xiaohui Deng, Wenyu Chen, Deqiang Huang, Lingyan Zhu, Xiaohua Yan, Hengyi Shao, Zhijun Luo und 1 weitere

Cancer Letters · 2026-08 · 653 · 218592

DOI: 10.1016/j.canlet.2026.218592 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2026-08. Verfasst von Zhimin Tang und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Transforming Growth Factor beta. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Jiangxi Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phosphatidylethanolamine binding protein 4 (PEBP4) is a multifunctional protein. The role of intracellular PEBP4 in cancer is well established. However, as a secreted protein, its extracellular functions have yet to be elucidated. Thus, the present study attempted to decipher the functions of the secreted PEBP4. Here, we demonstrated that PEBP4 was upregulated in colorectal cancer (CRC) specimens and was also elevated in the serum of CRC patients. Our results revealed that the secreted PEBP4 (sPEBP4) stimulated the proliferation and migration of colon cancer cells, an event that was prevented by treatment with antibodies against PEBP4 or by mutating the N-glycosylation site (N169 to Q). Our studies indicated that the action of sPEBP4 was different from that of its cellular counterpart. Further, co-injection of the sPEBP4 with colon cancer cells promoted tumorigenesis and lung metastasis in vivo. Mechanistically, sPEBP4 increased phosphorylation of Smad2/3 and Akt/mTOR, which was blocked by the TGFβRⅠ inhibitor SB525334, siRNA or a dominant-negative mutant of TGFβRI, but not by knockdown of IGF-1R or EGFR. In vitro surface plasmon resonance assay revealed that sPEBP4 directly associated with TGFβRs. Finally, sPEBP4 enhanced the stability of TGFβRI by upregulating USP4 through a mechanism similar to TGF-β. Collectively, our study for the first time demonstrates that sPEBP4 activates the TGF-β signaling pathway to promote CRC progression in a TGFβ-independent manner. This would prompt further studies to explore if sPEBP4 could serve as a potential candidate for colorectal cancer therapy or a biomarker for diagnosis, prognosis, and therapeutic responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsTransforming Growth Factor betaHumansAnimalsSignal TransductionCell ProliferationMiceDisease ProgressionCell MovementCell Line, TumorMaleFemaleMice, NudeGene Expression Regulation, NeoplasticPhosphatidylethanolamine Binding Protein

Stichwörter der Autor:innen

Colorectal cancer (CRC)MetastasisSecreted phosphatidylethanolamine binding protein 4 (sPEBP4)TGF-β signalingTumorigenesis

Substanzen

PE-binding protein 4, humanTransforming Growth Factor betaPhosphatidylethanolamine Binding Protein

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
  • Queen Mary School, Jiangxi Medical College, Nanchang University, 1299 Qianhu Avenue, Nanchang, Jiangxi, China.
  • Department of Endocrinology and Metabolism, The First Affiliated Hospital of Nanchang University, 17 Yongwaizheng Street, Nanchang, Jiangxi, China.
  • Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
  • Core ‬Facility ‬for ‬Biomedical ‬Science, ‬Nanchang ‬University, ‬Nanchang, Jiangxi, China.
  • School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China; Queen Mary School, Jiangxi Medical College, Nanchang University, 1299 Qianhu Avenue, Nanchang, Jiangxi, China. El…

Förderung

  • National Natural Science Foundation of China
  • Jiangxi Provincial Natural Science Foundation

Zitieren

APA

Tang, Z., Li, T., Yang, Z., Zhang, Y., Zhou, Y., Deng, X., Chen, W., Huang, D., Zhu, L., Yan, X., Shao, H., Luo, Z., & Luo, L. (2026). Secreted PEBP4 promotes colorectal cancer progression via regulation of the TGF-β signaling pathway. Cancer Letters, 653, 218592. https://doi.org/10.1016/j.canlet.2026.218592

Vancouver

Tang Z, Li T, Yang Z, Zhang Y, Zhou Y, Deng X, et al. Secreted PEBP4 promotes colorectal cancer progression via regulation of the TGF-β signaling pathway. Cancer Letters. 2026;653:218592. doi:10.1016/j.canlet.2026.218592

BibTeX
@article{Tang2026,
  author = {Tang, Zhimin and Li, Ting and Yang, Zaiqi and Zhang, Yilan and Zhou, Yan and Deng, Xiaohui and Chen, Wenyu and Huang, Deqiang and Zhu, Lingyan and Yan, Xiaohua and Shao, Hengyi and Luo, Zhijun and Luo, Lingyu},
  title = {Secreted PEBP4 promotes colorectal cancer progression via regulation of the TGF-β signaling pathway},
  journal = {Cancer Letters},
  year = {2026},
  volume = {653},
  pages = {218592},
  doi = {10.1016/j.canlet.2026.218592}
}
Kostenlos starten →